Physician profile
Randall C Bell
NPI 1780681403
$38,087.87
in general payments reported to CMS, 2019-2025
43 companies · $3,112 in 2025
The $3,112 reported for 2025 was more than what 83% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $12K · 2021: $2,283 · 2022: $2,850 · 2023: $3,269 · 2024: $3,464 · 2025: $3,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,822 · Education: $23.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,821.77 |
| Education | $23.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $19,138.15 | 2019-2022 | |
| Glaxosmithkline, LLC. | $3,947.80 | 2019-2025 | Arexvy, Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $3,219.77 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Mylan Specialty L.P. | $1,659.89 | 2019-2024 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,486.56 | 2019-2025 | Ofev, Jascayd |
| Regeneron Healthcare Solutions, INC. | $1,265.99 | 2019-2025 | Dupixent |
| Genzyme Corporation | $989.56 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $631.22 | 2021-2024 | Xarelto |
| Grifols USA, LLC | $543.95 | 2019-2025 | Prolastin-C Liquid |
| Insmed, INC. | $466.36 | 2022-2025 | Arikayce, Brinsupri |
| United Therapeutics Corporation | $456.77 | 2020-2025 | Tyvaso, Tyvaso |
| Electromed, INC. | $444.34 | 2021-2025 | Smartvest |
| Actelion Pharmaceuticals US, INC. | $441.86 | 2019-2021 | |
| Philips North America LLC | $430.66 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Amgen INC. | $351.47 | 2022-2025 | Tezspire |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $350.10 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
| Takeda Pharmaceuticals U.S.A., INC. | $305.28 | 2021-2025 | Glassia |
| Ani Pharmaceuticals, INC. | $219.55 | 2024-2025 | Purified Cortrophin Gel |
| Tactile Systems Technology INC | $219.40 | 2022-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Viatris Specialty LLC | $179.54 | 2025 | Yupelri |
| Pulmonx Corporation | $178.88 | 2022-2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Novartis Pharmaceuticals Corporation | $158.51 | 2021-2025 | |
| Mallinckrodt Hospital Products INC. | $145.56 | 2024-2025 | Acthar |
| Harmony Biosciences LLC | $130.46 | 2020-2022 | |
| Verona Pharma, INC. | $118.77 | 2025 | Ohtuvayre |
| Gilead Sciences, INC. | $88.58 | 2021-2023 | Veklury |
| Bayer Healthcare Pharmaceuticals INC. | $69.47 | 2020-2024 | |
| Merck Sharp & Dohme LLC | $48.31 | 2019-2025 | Winrevair |
| Csl Behring | $47.35 | 2021-2022 | |
| Advanced Respiratory, INC | $46.83 | 2020-2021 | |
| Portola Pharmaceuticals, LLC | $44.74 | 2019 | |
| Inogen, INC. | $40.17 | 2022-2024 | |
| Olympus America INC. | $40.05 | 2020-2022 | |
| Sunovion Pharmaceuticals INC. | $29.37 | 2019 | |
| Paratek Pharmaceuticals, INC. | $23.20 | 2023 | Nuzyra |
| Sanofi-Aventis U.S. LLC | $19.34 | 2021 | |
| Jazz Pharmaceuticals INC. | $18.05 | 2021 | |
| Ambu INC. | $17.11 | 2023 | |
| Fisher & Paykel Healthcare INC | $17.02 | 2022 | |
| Pfizer INC. | $15.49 | 2022 | |
| Azurity Pharmaceuticals, INC. | $15.36 | 2024 | Horizant |
| Circassia INC. | $14.16 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.